Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03944850 · ClinicalTrials.gov registry record · NA

Computerized Anxiety Sensitivity Treatment for Opioid Use Disorders

A NA study of Opioid Use Disorder, sponsored by Southeast Louisiana Veterans Health Care System.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT03944850 is a NA study of Opioid Use Disorder that has completed, run by Southeast Louisiana Veterans Health Care System. The registered enrollment target is 32 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03944850, a NA study of Opioid Use Disorder, has completed, sponsored by Southeast Louisiana Veterans Health Care System.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The primary aim of the current project is to test the acceptability and feasibility of a computerized intervention, titled Computerized Anxiety Sensitivity Treatment (CAST), delivered to Veterans seeking treatment for an opioid use disorder. The second aim of the study is to examine the utility of CAST by gathering data on symptom change. The final aim of the current study is to test the effects of CAST on rates of attendance and retention in a substance use disorder treatment (SUDT) program.

Conditions Studied

Interventions

  • BEHAVIORAL Computerized Anxiety Sensitivity Treatment

Study Locations (1)

Louisiana

  • Southeast Louisiana Veterans Health Care System - New Orleans

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2019-05-28
Est. Completion 2020-01-31
Phase NA

What the Registry Record Tells You About NCT03944850

The ClinicalTrials.gov registry entry for NCT03944850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Southeast Louisiana Veterans Health Care System, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Computerized Anxiety Sensitivity Treatment is the first listed.

NCT03944850 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT03944850 about?

NCT03944850 is a clinical study titled "Computerized Anxiety Sensitivity Treatment for Opioid Use Disorders". The primary aim of the current project is to test the acceptability and feasibility of a computerized intervention, titled Computerized Anxiety Sensitivity Treatment (CAST), delivered to Veterans seeking treatment for an opioid use disorder. The second aim of the study is to examine the utility of C...

What is the current status of trial NCT03944850?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-05-28. Estimated completion is 2020-01-31.

What conditions does trial NCT03944850 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT03944850?

The interventions under investigation include: Computerized Anxiety Sensitivity Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03944850?

This trial is sponsored by Southeast Louisiana Veterans Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03944850 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.